In the clip above from this morning’s edition of The Macro Show, Hedgeye CEO Keith McCullough and Director of Research Daryl Jones discuss positive news of a promising COVID-19 vaccine from Pfizer and the subsequent initial response from investors. While this development is clearly a step in the right direction, that does not mean going “back to normal” is going to occur overnight. In other words, some caution is in order.
